Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001057345 | SCV001221832 | uncertain significance | Brugada syndrome 5 | 2021-09-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002451237 | SCV002738854 | uncertain significance | Cardiovascular phenotype | 2018-05-11 | criteria provided, single submitter | clinical testing | The p.E84K variant (also known as c.250G>A), located in coding exon 3 of the SCN1B gene, results from a G to A substitution at nucleotide position 250. The glutamic acid at codon 84 is replaced by lysine, an amino acid with similar properties. This amino acid position is highly conserved through mammals but not in all available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. |
Fulgent Genetics, |
RCV002479349 | SCV002792514 | uncertain significance | Generalized epilepsy with febrile seizures plus, type 1; Brugada syndrome 5; Atrial fibrillation, familial, 13; Developmental and epileptic encephalopathy, 52 | 2021-09-20 | criteria provided, single submitter | clinical testing |